8-K/A
Current Report
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001171843-26-005168
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading f8ka_080326.htm…